| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CFO | President And CFO
1 company
Guggenhime Andrew is a President And CFO at Vaxcyte, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $5.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $25.26 | $78,320.24 | -3.5% | +65.7% | +90.4% | |
| Jul 18, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $24.53 | $76,047.23 | -3.5% | +7.9% | +94.7% | |
| Jul 8, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $24.00 | $74,400.00 | -6.8% | -1.8% | +95.3% | |
| May 18, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $24.44 | $75,762.80 | -3.5% | +5.8% | +102.4% | |
| Apr 18, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $24.05 | $74,542.29 | -7.1% | +1.7% | +87.0% | |
| Mar 18, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $26.13 | $80,992.77 | -7.1% | -27.9% | +44.6% | |
| Mar 1, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 6,200 | $24.00 | $148,800.00 | -66.5% | +0.6% | +74.8% | |
| Dec 23, 2021 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $24.00 | $74,400.00 | -49.8% | +0.5% | +93.2% | |
| Nov 18, 2021 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $24.53 | $76,030.50 | -32.8% | -16.6% | +79.5% |